42 Results for "

tauopathies

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "tauopathies" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-B0478
CAS No.: 25332-39-2
Synonyms: AF-1161
Trazodone hydrochloride (AF-1161) is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). Trazodone hydrochloride has anti-depressant and anti-insomnious activity. Trazodone hydrochloride exerts antagonistic properties against a1- and a2-adrenergic receptors and histamine H1 receptors, with minimal anticholinergic effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134968
CAS No.: 2735015-60-6
Purity:  99.53%
Target:  

Tau Protein

Research Areas:  

Neurological Disease

TTBK1-IN-1 is a potent, selective and brain-penetrant tau tubulin kinase 1 (TTBK1) inhibitor with an IC50 of 2.7 nM. TTBK1-IN-1 can be used for the research of alzheimer’s disease and related tauopathies . TTBK1-IN-1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-D0961
CAS No.: 1562-85-2
Gallocyanine chloride is a synthetic blue dyestuff that can be used as a potential agent for the research of Alzheimer's disease and related neurodegenerative tauopathies. Gallocyanine chloride inhibits DKK1/LRP6 interaction (IC50=6.38 μM), activates Wnt signaling pathway, and causes β-catenin accumulation. Gallocyanine chloride exhibits anti-metastasis, anti-inflammatory and anti-fibrosis activities. Gallocyanine chloride can be used as a fluorescent probe for detection of superoxide anion radicals .
loading...
    loading...
Cat. No.: HY-W143216
CAS No.: 531-57-7
Synonyms: Monomethylthionine
Target:  

Amyloid-β Tau Protein HSP

Research Areas:  

Neurological Disease

Azure C (Monomethylthionine) acts as a tau oligomer inhibitor and Aβ42 oligomerization inhibitor. Azure C regulates hsp70 ATPase activity, thereby mediating the clearance of tau protein. Azure C reduces the levels of toxic tau oligomers by promoting the formation of non-toxic tau aggregates, rescues neuroblastoma cells from tau oligomer-induced toxicity, and binds to and inhibits Aβ42 oligomerization. Azure C is generated via continuous oxidation of methylene blue or azure B through a horseradish peroxidase-mediated reaction. Azure C can be used in research related to tauopathies, including Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-161307
CAS No.: 2276680-91-0
Research Areas:  

Neurological Disease

T-518 is an orally active, BBB-penetrant and potent DFMO-based HDAC6 inhibitor with high selectivity (IC50 = 36 nM). T-518 improves axonal transport. T-518 ameliorates object recognition deficit. T-518 can be studied in research for Alzheimer’s disease and tauopathy .
loading...
    loading...
Cat. No.: HY-144681
CAS No.: 2241514-56-5
Purity:  99.09%
Synonyms: LY3372689
Target:  

OGA Tau Protein

Research Areas:  

Neurological Disease

Ceperognastat (LY3372689) is an orally active O-GlcNAcase (OGA) enzyme inhibitor. Ceperognastat can be used for tauopathies research, including Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-132582C
Purity:  91.82%
Synonyms: IONIS-MAPTRx sodium; BIIB080 sodium; ISIS 814907 sodium
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Diranersen (IONIS-MAPTRx) sodium is an antisense oligonucleotide that targets the human MAPT gene to inhibit the production of tau protein. Diranersen sodium can be used in research related to Alzheimer's disease and tauopathies .
loading...
    loading...
Cat. No.: HY-156586
CAS No.: 1884154-02-2
Purity:  99.63%
Synonyms: ASN90
Target:  

OGA Tau Protein

Research Areas:  

Neurological Disease

Egalognastat (ASN90) is a selective, brain-penetrant and orally active O-GlcNAcase (OGA) enzyme inhibitor with an IC50 value of 10.2 nM. Egalognastat increases O-GlcNAcylation of intracellular proteins like tau and α-synuclein, preventing their aggregation and toxicity. Egalognastat does not inhibit hexosaminidase (Hex). Egalognastat can be used for the research of neurodegenerative diseases, such as tauopathies and α-synucleinopathies (e.g., Alzheimer’s disease and Parkinson’s disease) .
loading...
    loading...
Cat. No.: HY-P10861A
Target:  

Tau Protein

Research Areas:  

Neurological Disease

RI-AG03 acetate is a proteolytically stable tau aggregation inhibitor that crosses the blood-brain barrier and exhibits oral efficacy. RI-AG03 acetate inhibits tau aggregation and promotes the formation of alternative amorphous aggregates that are non-amyloidogenic. RI-AG03 acetate mediates cellular uptake through direct membrane penetration and macropinocytosis, and its conjugation with cell-penetrating peptide sequences (CPPs) enhances the binding of cells to liposomes. RI-AG03 acetate suppresses aggregation-dependent neurodegenerative and behavioral phenotypes, and extends the lifespan of Drosophila models of tauopathy. RI-AG03 acetate can be used for research on tau-related diseases such as Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-137557
CAS No.: 1565797-16-1
Synonyms: APN1607; PM-PBB3
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Florzolotau (APN1607) is a positron emission tomography (PET) ligand that can be used for the detection of Alzheimer's disease (AD) and other tau proteinopathies. Its binding sites are located in the β-sheet of paired helical filaments (PHFs) and straight filaments (SFs) of tau protein, as well as in the C-shaped cavity of SFs. In addition, APN-1607 binds to intraneuronal inclusions in Alzheimer's disease (AD), primary age-related tauopathy (PART) and posterior cortical atrophy (PCA). Florzolotau shows promise for PET imaging studies of neurological disorders, particularly tau proteinopathies .
loading...
    loading...
Cat. No.: HY-132582
CAS No.: 2304711-06-4
Synonyms: IONIS-MAPTRx; BIIB080; ISIS 814907
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Diranersen (IONIS-MAPTRx) is an antisense oligonucleotide that targets the human MAPT gene to inhibit the production of tau protein. Diranersen can be used in research related to Alzheimer's disease and tauopathies .
loading...
    loading...
Cat. No.: HY-P99163
CAS No.: 2096513-89-0
Synonyms: ABBV-8E12; C2N-8E12

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Tilavonemab (ABBV-8E12) is a humanized anti-tau monoclonal antibody that binds to amino acids 25-30 near the N-terminus of the tau protein. Tilavonemab can block the ability of human and mouse neurons to uptake tau aggregates. Tilavonemab can be used for research on Alzheimer’s disease and other tauopathies .
loading...
    loading...
Cat. No.: HY-174311
CAS No.: 2648407-76-3
Target:  

Glycosidase

GT-02216 can bind to GCase allosterically and enhance its activity. GT-02216 enhances the activity of GCase in primary human fibroblasts dose-dependently reduces the accumulation of its substrate, hexosylsphingosine (HexCer). GT-02216 reduces the Tau accumulation in mutant GBA1 fibroblasts. GT-02216 can be used for the study of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-P10861
Target:  

Tau Protein

Research Areas:  

Neurological Disease

RI-AG03 is a proteolytically stable tau aggregation inhibitor that crosses the blood-brain barrier and exhibits oral efficacy. RI-AG03 inhibits tau aggregation and promotes the formation of alternative amorphous aggregates that are non-amyloidogenic. RI-AG03 mediates cellular uptake through direct membrane penetration and macropinocytosis, and its conjugation with cell-penetrating peptide sequences (CPPs) enhances the binding of cells to liposomes. RI-AG03 suppresses aggregation-dependent neurodegenerative and behavioral phenotypes, and extends the lifespan of Drosophila models of tauopathy. RI-AG03 can be used for research on tau-related diseases such as Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-148112
CAS No.: 851871-94-8
Purity:  99.91%
Target:  

Casein Kinase

Research Areas:  

Neurological Disease

Casein kinase 1δ-IN-1 is an inhibitor of casein kinase 1δ (CK1δ). Casein kinase 1δ-IN-1 can be used for the research of neurodegenerative diseases such as tauopathies .
loading...
    loading...
Cat. No.: HY-151335
CAS No.: 1160952-43-1
Target:  

HSP

Research Areas:  

Cancer

KU-177 is a potent inhibitor of Hsp90 ATPase homologue 1 (Aha1), ablates Aha1-driven enhancement of Hsp90-dependent tau aggregation. KU-177 also disrupts Aha1/Hsp90 interactions (IC50=4.08 μM) without inhibition of Hsp90’s ATPase activity. KU-177 can be used for tauopathies research .
loading...
    loading...
Cat. No.: HY-P4943
CAS No.: 1663490-91-2
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Tau Peptide (273-284) is a Tau fragment. Tau Peptide (273-284) can be used in the research of tauopathies, especially Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W046071
CAS No.: 203866-14-2
Target:  

Drug Intermediate

Research Areas:  

Others

N-Boc-trans-4-fluoro-L-proline is a non-natural amino acid substitute used to construct monoclonal antibodies that specifically target the seed conformation of tau protein .
loading...
    loading...
Cat. No.: HY-176540
CAS No.: 2699937-76-1
Target:  

Microtubule/Tubulin

Research Areas:  

Neurological Disease

Microtubule stabilizer-1 (compound 69) is a brain-penetrant microtubule (MT) stabilizer. Microtubule stabilizer-1 increases acetylated α-tubulin (AcTub) levels and prevents the characteristic loss of neuronal MTs that is observed after incubation with Okadaic acid (HY-N6785). Microtubule stabilizer-1 can be used for the study of Alzheimer’s disease (AD) and related neurodegenerative tauopathies .
loading...
    loading...
Cat. No.: HY-154987
Purity:  98.23%
Target:  

MARK

Research Areas:  

Cancer

MARK4 inhibitor 3 (compound 23b) is an inhibitor of MARK4 with an IC50 value of 1.01 μM. MARK4 inhibitor 3 inhibits cancer cells growth. MARK4 inhibitor 3 can be used for research on cancer and tauopathies .
loading...
    loading...